New research from #ASCO26 shows that fasting before and after chemo can help reduce insulin levels and may improve improve treatment response for certain people with #ovariancancer. @DrTeplinsky explains more in our latest Science in Seconds: https://t.co/0rMwyOXWtx
#gyncsm
Thanks for having me @NewsNation and @annakooiman56 🚨🚨. Always ready to share knowledge 🧠🧐 of my day to day and help women (and men) stay away from this disruptive, scary journey 🎀🩷@LevineCancer @LCI_YWBP https://t.co/lWXdrPfErp
Congrats Dr. Natalie Reed who presented her work on social determinants of health in breast oncology at AACR in San Diego today. This is one to watch! LCI is proud of you. @LevineCancer#bcsm@Dr_LHG@atanmdlci
#monarchE 5 yr efficacy updates
Abema improved:
*️⃣IDFS by 7.6% at 4 yrs
*️⃣DRFS improved by 6.7%
💡 fewer pts with metastatic disease
👏 this continues to widen with further follow up
#ESMO23#bcsm
The part here that is absolutely sobering 😢 :
For the 👨🏽 👩🏼 going through all this chemo & treatment for half a year who don't have pCR, their chance at cure is only 50-60%.
Here is where we need new trials 📊 and development 💊 - nonpCR adjuvant TNBC.
Learn about coping strategies for #breastcancer from Atrium Health Levine Cancer’s Dr. Arielle Heeke, a breast cancer oncologist, on October 25. Details about this upcoming virtual workshop⬇️
#Drugshortages are impacting thousands of individuals w/ cancer, including your constituents @jeffjacksonnc. Consider signing a Dear Colleague Letter to @US_FDA urging for collaboration and swift action to mitigate these shortages. #ASCOAdvocacy https://t.co/R3eiJR6rkj
Interesting @JNCI_Now article challenging a fossilized dogma. Authors followed a stage-stratified random sample of 10.000 women w/ stage II-III BC for 10 yrs, finding an improvement in OS for surveillance imaging among TNBC & HER2+ (but not HR+/HER2-) 1/2
https://t.co/SNLzs3k28J
Dr. Daniel Haggstrom from @LevineCancer kicks off #gotoPER ASCO Direct.
He saves the day saves in #Nashville, presenting ASCO 2022 updates virtually from Charlotte due to a faculty member being sick in Nashville. 👏
#onctwitter#lcsm
Fantastic article in @ASCO education book by @MeganTesch and @AnnPartridgeMD re: #bcsm in young women including pearls re:
- chemo ammenorrhea rates w/ various chemo
-surgical choice trends and outcome
-ovarian suppression
https://t.co/e6a2Kqova1
Happening now, @DCarrizosaMD presenting at DT oral session on CRESTONE, phI trial seribantumab in solid tumor with NRG1 gene fusions - tune in #ASCO22@LevineCancer